Localization of Epstein-Barr virus cytotoxic T cell epitopes using recombinant vaccinia: implications for vaccine development.Rajiv Khanna, Denis J. Moss, Scott R. Burrows et al.|The Journal of Experimental Medicine|1992Cited by 391
Dominant selection of an invariant T cell antigen receptor in response to persistent infection by Epstein-Barr virus.Victor Argaet, I S Misko, Michael G. Kurilla et al.|The Journal of Experimental Medicine|1994Cited by 281
Human cytotoxic T-cell responses against Epstein-Barr virus nuclear antigens demonstrated by using recombinant vaccinia viruses.R J Murray, Elliott Kieff, Michael G. Kurilla et al.|Proceedings of the National Academy of Sciences|1990Cited by 103
Isolation of Cytotoxic T Lymphocytes from Healthy Seropositive Individuals Specific for Peptide Epitopes from Epstein–Barr Virus Nuclear Antigen 1: Implications for Viral Persistence and Tumor Surveillance1Rajiv Khanna, Denis J. Moss, Scott R. Burrows et al.|Virology|1995Cited by 85
Expression of Epstein-Barr virus nuclear antigens in anti-IgM-stimulated B cells following recombinant vaccinia infection and their recognition by human cytotoxic T cells.Rajiv Khanna, Denis J. Moss, Catherine Jacob et al.|PubMed|1991Cited by 35